MNPR MONOPAR THERAPEUTICS Capital Structure Changes 8-K Filing 2024 - Nasdaq Compliance Monopar Therapeutics announced that it has regained compliance with Nasdaq's minimum bid price rule as of August 27, 2024.Get access to all SEC 8-K filings of the MONOPAR THERAPEUTICS